uniQure N.V (NASDAQ: QURE) on Tuesday, soared 6.84% from the previous trading day, before settling in for the closing price of $11.70. Within the past 52 weeks, QURE’s price has moved between $3.73 and $19.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 323.68%. The company achieved an average annual earnings per share of 20.86%. With a float of $47.24 million, this company’s outstanding shares have now reached $48.99 million.
Let’s determine the extent of company efficiency that accounts for 209 employees. In terms of profitability, gross margin is 12.88%, operating margin of -696.25%, and the pretax margin is -874.39%.
uniQure N.V (QURE) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of uniQure N.V is 12.63%, while institutional ownership is 75.95%. The most recent insider transaction that took place on Mar 04 ’25, was worth 291,629. In this transaction CEO, Managing Director of this company sold 28,341 shares at a rate of $10.29, taking the stock ownership to the 651,454 shares. Before that another transaction happened on Mar 04 ’25, when Company’s Chief Medical Officer sold 1,350 for $10.29, making the entire transaction worth $13,891. This insider now owns 151,903 shares in total.
uniQure N.V (QURE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.66% during the next five years compared to -9.66% drop over the previous five years of trading.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
uniQure N.V (QURE) is currently performing well based on its current performance indicators. A quick ratio of 9.74 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.92, a number that is poised to hit -0.98 in the next quarter and is forecasted to reach -3.04 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Looking closely at uniQure N.V (NASDAQ: QURE), its last 5-days average volume was 0.86 million, which is a drop from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 63.16%. Additionally, its Average True Range was 1.11.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 51.70%, which indicates a significant decrease from 73.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 117.20% in the past 14 days, which was lower than the 149.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.43, while its 200-day Moving Average is $8.74. However, in the short run, uniQure N.V’s stock first resistance to watch stands at $12.94. Second resistance stands at $13.37. The third major resistance level sits at $14.12. If the price goes on to break the first support level at $11.76, it is likely to go to the next support level at $11.01. Should the price break the second support level, the third support level stands at $10.58.
uniQure N.V (NASDAQ: QURE) Key Stats
Market capitalization of the company is 675.96 million based on 54,077K outstanding shares. Right now, sales total 27,120 K and income totals -239,560 K. The company made 5,220 K in profit during its latest quarter, and -73,260 K in sales during its previous quarter.
